QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 281 filers reported holding QIAGEN NV in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,750 | -10.0% | 43,200 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $1,945 | +21.7% | 43,200 | +24.1% | 0.01% | +11.1% |
| Q1 2023 | $1,598 | +0.8% | 34,800 | +9.4% | 0.01% | -10.0% |
| Q4 2022 | $1,586 | -99.9% | 31,800 | 0.0% | 0.01% | +11.1% |
| Q3 2022 | $1,313,000 | -12.5% | 31,800 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $1,501,000 | +0.1% | 31,800 | +3.9% | 0.01% | +25.0% |
| Q1 2022 | $1,499,000 | -28.1% | 30,600 | -18.4% | 0.01% | -20.0% |
| Q4 2021 | $2,084,000 | -8.2% | 37,500 | -14.6% | 0.01% | -16.7% |
| Q3 2021 | $2,269,000 | +21.5% | 43,900 | +13.7% | 0.01% | +20.0% |
| Q2 2021 | $1,867,000 | -6.9% | 38,600 | -6.3% | 0.01% | -9.1% |
| Q1 2021 | $2,006,000 | -7.9% | 41,200 | 0.0% | 0.01% | -15.4% |
| Q4 2020 | $2,177,000 | +1.1% | 41,200 | 0.0% | 0.01% | -18.8% |
| Q3 2020 | $2,153,000 | +22.1% | 41,200 | 0.0% | 0.02% | +128.6% |
| Q2 2020 | $1,764,000 | – | 41,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |